169 related articles for article (PubMed ID: 8923412)
21. Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation.
Azziz R; Wells G; Zacur HA; Acton RT
J Clin Endocrinol Metab; 1991 Dec; 73(6):1327-31. PubMed ID: 1955515
[TBL] [Abstract][Full Text] [Related]
22. [Polycystic ovary syndrome of extra-ovarian origin. Review].
Terán Dávila J; Teppa-Garrán AD
Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
[TBL] [Abstract][Full Text] [Related]
23. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.
Wheatland R
Med Hypotheses; 2005; 65(2):287-95. PubMed ID: 15885924
[TBL] [Abstract][Full Text] [Related]
24. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
25. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women.
Carmina E; Dewailly D; Escobar-Morreale HF; Kelestimur F; Moran C; Oberfield S; Witchel SF; Azziz R
Hum Reprod Update; 2017 Sep; 23(5):580-599. PubMed ID: 28582566
[TBL] [Abstract][Full Text] [Related]
26. Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Moran C; Azziz R; Weintrob N; Witchel SF; Rohmer V; Dewailly D; Marcondes JA; Pugeat M; Speiser PW; Pignatelli D; Mendonca BB; Bachega TA; Escobar-Morreale HF; Carmina E; Fruzzetti F; Kelestimur F
J Clin Endocrinol Metab; 2006 Sep; 91(9):3451-6. PubMed ID: 16822826
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism.
Unluhizarci K; Kula M; Dundar M; Tanriverdi F; Israel S; Colak R; Dokmetas HS; Atmaca H; Bahceci M; Balci MK; Comlekci A; Bilen H; Akarsu E; Erem C; Kelestimur F
Gynecol Endocrinol; 2010 Feb; 26(2):139-43. PubMed ID: 19718570
[TBL] [Abstract][Full Text] [Related]
28. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender.
Moran C; Azziz R
Semin Reprod Med; 2003 Aug; 21(3):295-300. PubMed ID: 14593552
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of adrenal steroidogenesis in childhood: changes in the excretion of 16-oxygenated- and 11-oxygenated-steroids by 21-hydroxylase deficient children at various ages.
Kecskés L
Endokrinologie; 1982 Oct; 80(2):151-7. PubMed ID: 6297879
[TBL] [Abstract][Full Text] [Related]
30. 11beta-hydroxyandrostenedione and delta5-androstenediol as markers of adrenal androgen production in patients with 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Huerta R; Dewailly D; Decanter C; Knochenhauer ES; Boots LR; Azziz R
Fertil Steril; 1999 Dec; 72(6):996-1000. PubMed ID: 10593370
[TBL] [Abstract][Full Text] [Related]
31. Amenorrhea related to progestin excess in congenital adrenal hyperplasia.
Rosenfield RL; Bickel S; Razdan AK
Obstet Gynecol; 1980 Aug; 56(2):208-15. PubMed ID: 7393510
[TBL] [Abstract][Full Text] [Related]
32. Adrenal steroidogenesis and congenital adrenal hyperplasia.
Turcu AF; Auchus RJ
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):275-96. PubMed ID: 26038201
[TBL] [Abstract][Full Text] [Related]
33. Non-classic congenital adrenal hyperplasia.
Kelestimur F
Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():451-4. PubMed ID: 17551465
[TBL] [Abstract][Full Text] [Related]
34. Androgens in Congenital Adrenal Hyperplasia.
Pignatelli D; Pereira SS; Pasquali R
Front Horm Res; 2019; 53():65-76. PubMed ID: 31499506
[TBL] [Abstract][Full Text] [Related]
35. Nonclassic 21-hydroxylase deficiency.
Dewailly D
Semin Reprod Med; 2002 Aug; 20(3):243-8. PubMed ID: 12428204
[TBL] [Abstract][Full Text] [Related]
36. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Merke DP; Bornstein SR; Avila NA; Chrousos GP
Ann Intern Med; 2002 Feb; 136(4):320-34. PubMed ID: 11848730
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid Activity of Adrenal Steroid Precursors in Untreated Patients With Congenital Adrenal Hyperplasia.
Engels M; Pijnenburg-Kleizen KJ; Utari A; Faradz SMH; Oude-Alink S; van Herwaarden AE; Span PN; Sweep FC; Claahsen-van der Grinten HL
J Clin Endocrinol Metab; 2019 Nov; 104(11):5065-5072. PubMed ID: 31090904
[TBL] [Abstract][Full Text] [Related]
38. [Cortico-adrenal-genital syndrome. Diagnosis, therapy, follow-up].
Gargantini L; Trifirò G; Bianchi C; Chiumello G
Pediatr Med Chir; 1985; 7(4):487-90. PubMed ID: 3016673
[TBL] [Abstract][Full Text] [Related]
39. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.
Falhammar H; Nordenström A
Endocrine; 2015 Sep; 50(1):32-50. PubMed ID: 26082286
[TBL] [Abstract][Full Text] [Related]
40. [Sexual and gonadal dysfunction in adrenal disorders].
Horiba N
Nihon Rinsho; 1997 Nov; 55(11):2979-84. PubMed ID: 9396299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
